Cardiol Therapeutics Inc. (CRDL.TO)
CAD 1.45
(10.69%)
CAD 1.45
(10.69%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -28.12 Million CAD | -144.12% |
| 2022 | -11.52 Million CAD | 53.4% |
| 2021 | -24.72 Million CAD | -19.74% |
| 2020 | -20.64 Million CAD | -47.66% |
| 2019 | -13.98 Million CAD | 12.02% |
| 2018 | -15.89 Million CAD | -856.92% |
| 2017 | -1.66 Million CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -6.59 Million CAD | 28.2% |
| 2024 Q1 | -9.17 Million CAD | -20.2% |
| 2023 Q4 | -7.63 Million CAD | -28.78% |
| 2023 FY | -28.12 Million CAD | -144.12% |
| 2023 Q3 | -5.93 Million CAD | 20.63% |
| 2023 Q2 | -7.47 Million CAD | -19.71% |
| 2023 Q1 | -6.24 Million CAD | -26.36% |
| 2022 Q2 | -6.68 Million CAD | 25.99% |
| 2022 Q1 | -9.02 Million CAD | -44.25% |
| 2022 FY | -11.52 Million CAD | 53.4% |
| 2022 Q4 | -4.93 Million CAD | 40.92% |
| 2022 Q3 | -8.36 Million CAD | -25.15% |
| 2021 Q1 | -8.9 Million CAD | 7.83% |
| 2021 Q2 | -6.56 Million CAD | 26.36% |
| 2021 Q3 | -9.9 Million CAD | -51.05% |
| 2021 Q4 | -6.25 Million CAD | 36.86% |
| 2021 FY | -24.72 Million CAD | -19.74% |
| 2020 FY | -20.64 Million CAD | -47.66% |
| 2020 Q4 | -9.66 Million CAD | -119.63% |
| 2020 Q3 | -4.4 Million CAD | -21.43% |
| 2020 Q2 | -3.62 Million CAD | -22.92% |
| 2020 Q1 | -2.94 Million CAD | 3.6% |
| 2019 Q1 | -3.49 Million CAD | 61.53% |
| 2019 FY | -13.98 Million CAD | 12.02% |
| 2019 Q2 | -3.64 Million CAD | -4.35% |
| 2019 Q4 | -3.05 Million CAD | 12.4% |
| 2019 Q3 | -3.49 Million CAD | 4.14% |
| 2018 Q4 | -9.07 Million CAD | -84.79% |
| 2018 Q1 | -551.63 Thousand CAD | 6.23% |
| 2018 FY | -15.89 Million CAD | -856.92% |
| 2018 Q2 | -1.35 Million CAD | -146.23% |
| 2018 Q3 | -4.91 Million CAD | -261.5% |
| 2017 Q4 | -588.26 Thousand CAD | -9.8% |
| 2017 Q2 | -442.55 Thousand CAD | 0.0% |
| 2017 Q3 | -535.73 Thousand CAD | -21.05% |
| 2017 FY | -1.66 Million CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aurora Cannabis Inc. | -69.32 Million CAD | 59.426% |
| Avicanna Inc. | -8.74 Million CAD | -221.723% |
| Avant Brands Inc. | -5.07 Million CAD | -454.799% |
| Crescita Therapeutics Inc. | -1.98 Million CAD | -1316.329% |
| Knight Therapeutics Inc. | -16.83 Million CAD | -67.082% |
| MediPharm Labs Corp. | -13.08 Million CAD | -114.999% |
| OrganiGram Holdings Inc. | -229.47 Million CAD | 87.742% |
| Canopy Growth Corporation | -657.26 Million CAD | 95.72% |
| Willow Biosciences Inc. | -13.02 Million CAD | -115.89% |
| Auxly Cannabis Group Inc. | -44.51 Million CAD | 36.806% |